18 Seth Klarman Theravance Biopharma Trades
The first Theravance Biopharma trade was made in Q2 2014. Since then Seth Klarman bought shares eight more times and sold shares on nine occasions. The investor completely sold their stake between Q1 2022 and Q3 2024.
Avg closing price
Price range
Sold -4.2 Million shares
Q3 2024
Avg closing price
$8.65
Price range
$7.66
-
$10.25
Sold 36.3% shares (-2.39 Million shares)
Q2 2024
Avg closing price
$9.03
Price range
$8.29
-
$9.92
Sold 11.1% shares (-825 Thousand shares)
Q1 2024
Avg closing price
$9.27
Price range
$8.22
-
$11.59
Sold 28.8% shares (-3 Million shares)
Q2 2023
Avg closing price
$11.04
Price range
$10.16
-
$11.92
Sold 8.8% shares (-1 Million shares)
Q1 2023
Avg closing price
$10.57
Price range
$9.87
-
$11.44
Sold 14.9% shares (-2 Million shares)
Q4 2022
Avg closing price
$10.51
Price range
$9.65
-
$11.34
Sold 1.6% shares (-224 Thousand shares)
Q2 2022
Avg closing price
$9.21
Price range
$8.41
-
$10.34
Sold 0.1% shares (-16.8 Thousand shares)
Q1 2022
Avg closing price
$9.80
Price range
$8.33
-
$12.96
Increased shares by 37.8% (+3.75 Million shares)
Q3 2021
Avg closing price
$11.19
Price range
$6.77
-
$14.41
Increased shares by 13.5% (+1.18 Million shares)
Q2 2021
Avg closing price
$18.78
Price range
$14.52
-
$22.46
Sold 6.2% shares (-574 Thousand shares)
Q3 2020
Avg closing price
$18.73
Price range
$14.78
-
$22.49
Increased shares by 0.4% (+35.2 Thousand shares)
Q3 2017
Avg closing price
$32.70
Price range
$23.88
-
$42.56
Increased shares by 26.2% (+1.92 Million shares)
Q4 2016
Avg closing price
$31.02
Price range
$24.57
-
$38.58
Increased shares by 13.1% (+850 Thousand shares)
Q2 2016
Avg closing price
$21.59
Price range
$17.45
-
$24.20
Increased shares by 1.3% (+81 Thousand shares)
Q1 2016
Avg closing price
$16.36
Price range
$13.35
-
$18.80
Increased shares by 0.8% (+53.5 Thousand shares)
Q2 2015
Avg closing price
$15.51
Price range
$12.57
-
$18.63
Increased shares by 5.0% (+305 Thousand shares)
Q1 2015
Avg closing price
$18.33
Price range
$14.70
-
$21.73
New holding (+6.06 Million shares)
Q2 2014
Avg closing price
$30.10
Price range
$23.51
-
$34.87
